This increased CXCL10 induction correlated with higher frequency of intratumoral CXCR3+ CD8+ T cells (Fig. 5b), demonstrating that reversal of epigenetic silencing of STING using a demethylating agent can promote tumor infiltration of CD8+ T cells. The gene discussed is CXCR3; the disease is neoplasm.